American pharmaceutical company Pfizer’s chief executive officer said Sunday that there is a good chance the company will know whether its CCP virus vaccine is effective by the end of October.
Pfizer head Albert Bourla said during an appearance on CBS’s “Face the Nation” that, based on the company’s studies, the efficacy of the vaccine candidate it is developing in partnership with BioNTech SE will be known by the end of next month.